NCT02077010View on ClinicalTrials.gov

Nebulized Inhaled Milrinone in a Hospitalized Advanced Heart Failure Population

PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

June 15, 2020

Primary Completion Date

January 24, 2023

Study Completion Date

January 24, 2023

Conditions
Heart FailureCardiomyopathy
Interventions
DRUG

Inhaled nebulized milrinone

inhaled nebulized milrinone 60mg/4ml

Trial Locations (2)

37204

Vanderbilt University Medical Center, Nashville

66160

University of Kansas Medical Center, Kansas City

All Listed Sponsors
collaborator

Vanderbilt University Medical Center

OTHER

lead

University of Kansas Medical Center

OTHER

NCT02077010 - Nebulized Inhaled Milrinone in a Hospitalized Advanced Heart Failure Population | Biotech Hunter | Biotech Hunter